CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Joshua Aviram

OPENALEX: A5037351932↗ORCID: 0000-0003-2075-5446↗

Affiliations

Organizations

Ariel Universityauthorship · IL Rambam Health Care Campusauthorship · IL Technion – Israel Institute of Technologyauthorship · IL University of Haifaauthorship · IL

Public evidence

7 connected articles

Medical cannabis in Israel: a comprehensive review of trends and regulations, 2011-2025.2025 · Europe PMC The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients.2022 · PubMed Central Open Access THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial.2022 · Europe PMC Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients.2021 · PubMed Central Open Access Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients.2020 · PubMed Central Open Access Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study.2020 · PubMed Central Open Access Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients.2020 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Joshua Aviram - Medical Cannabis Research Engine